Adverse systemic arterial function in patients with selenium deficiency
- 153 Downloads
Experimental studies have shown that selenium is involved in the synthesis of selenoproteins which might contribute to cardiovascular protection. However, the relationship between selenium deficiency and vascular function in clinical context remains unknown.
To investigate for any relationship between selenium deficiency and systemic arterial function in patients with high risk of vascular events.
Setting and Participants
306 consecutive patients with high risk for cardiovascular events (coronary artery disease 35%, acute/recurrent ischemic stroke 40%, diabetes mellitus 54%) followed up at internal medicine outpatient clinics.
Non-invasive brachial-ankle pulse wave velocity (PWV) was determined using vascular profiling system (VP-2000). Long-term intake of selenium was determined by a validated food frequency questionnaire.
Mean daily selenium intake was 59.5 ± 52.1 mcg/day, and mean PWV was 1782.4 ± 418.4 cm/s. Patients with selenium intake <10th percentile had significantly higher PWV as compared to patients with intake 10th percentile (1968.2 ± 648.9 cm/s versus 1762.2 ± 381.6 cm/s, P=0.010). After adjusting for potential confounders including age, gender, history of hypertension, hyperlipidemia, diabetes and cardiovascular disease, smoking status, use of cardiovascular medications, waist-hip ratio, education/financial status, physical activity, calorie intake and intake of antioxidant vitamins, deficient selenium intake <10th percentile remained independently predictive of increased PWV by +363.4 cm/s [95% CI: 68.1 to 658.6, P=0.016, relative increase 21%].
Selenium deficiency is associated with adverse arterial function in patients with high risk for vascular events.
Key wordsSelenium deficiency arterial stiffness vascular function nutrition secondary prevention
Unable to display preview. Download preview PDF.
- 12.Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, et al. Arterial Stiffness and Cardiovascular Events. The Framingham Heart Study. Circulation. 2010 Jan 18.Google Scholar
- 14.Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation. 2006 Dec 19;114(25):2850–2870.PubMedCrossRefGoogle Scholar
- 15.Papp LV, Holmgren A, Khanna KK. Selenium and selenoproteins in health and disease. Antioxid Redox Signal. 2009 Nov 11.Google Scholar
- 22.Lubos E, Sinning CR, Schnabel RB, Wild PS, Zeller T, Rupprecht HJ, et al. Serum selenium and prognosis in cardiovascular disease: results from the AtheroGene study. Atherosclerosis. 2009 Sep 12.Google Scholar
- 27.Schnabel R, Lubos E, Messow CM, Sinning CR, Zeller T, Wild PS, et al. Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study. Am Heart J. 2008 Dec;156(6):1201 e1–11.CrossRefGoogle Scholar